For: | Poulose JV, Kainickal CT. Immune checkpoint inhibitors in head and neck squamous cell carcinoma: A systematic review of phase-3 clinical trials. World J Clin Oncol 2022; 13(5): 388-411 [PMID: 35662989 DOI: 10.5306/wjco.v13.i5.388] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v13/i5/388.htm |
Number | Citing Articles |
1 |
Kedar Kirtane, Maie St. John, Harry Fuentes-Bayne, Sandip P. Patel, Armen Mardiros, Han Xu, Eric W. Ng, William Y. Go, Deborah J. Wong, John B. Sunwoo, John S. Welch. Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas. Journal of Clinical Medicine 2022; 11(24): 7259 doi: 10.3390/jcm11247259
|
2 |
Ruey-Long Hong, Chia-Jui Yen, Ming-Yu Lien, Rebecca Cheng, Yu-Wen Su, Han-Nan Lin, Song Ling Poon, Chih-Yen Chien. Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study. Oral Oncology 2024; 152: 106760 doi: 10.1016/j.oraloncology.2024.106760
|
3 |
Helene Hersvik Aarstad, Svein Erik Emblem Moe, Stein Lybak, Øystein Bruserud, Tor Henrik Anderson Tvedt, Hans Jørgen Aarstad. Plasma IL-1 and IL-6 Family Cytokines with Soluble Receptor Levels at Diagnosis in Head and Neck Squamous Cell Carcinoma: High Levels Predict Decreased Five-Year Disease-Specific and Overall Survival. Cancers 2024; 16(8): 1484 doi: 10.3390/cancers16081484
|
4 |
Jiaqi Han, Ni Zeng, Kun Tian, Zijian Liu, Longjiang She, Zhu Wang, Jinlan He, Nianyong Chen. First‐line immunotherapy combinations for recurrent or metastatic nasopharyngeal carcinoma: An updated network meta‐analysis and cost‐effectiveness analysis. Head & Neck 2023; 45(9): 2246 doi: 10.1002/hed.27452
|
5 |
Daniel A. Ruiz-Torres, Saskia Naegele, Archana Podury, Lori Wirth, Sophia Z. Shalhout, Daniel L. Faden. Immunotherapy time of infusion impacts survival in head and neck cancer: A propensity score matched analysis. Oral Oncology 2024; 151: 106761 doi: 10.1016/j.oraloncology.2024.106761
|
6 |
Svein Erik Moe, Fredrik A. Erland, Siren Fromreide, Stein Lybak, Marianne Brydoy, Harsh N. Dongre, Sophia M. Dhayalan, Daniela-Elena Costea, Olav K. Vintermyr, Hans Jørgen Aarstad. The TP53 Codon 72 Arginine Polymorphism Is Found with Increased TP53 Somatic Mutations in HPV(−) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients. Biomedicines 2023; 11(7): 1838 doi: 10.3390/biomedicines11071838
|
7 |
Maximilian Rink, Ernst-Michael Jung, Julian Künzel. The Use of Contrast-Enhanced Sonography for Therapy Monitoring of Metastatic Lymph Nodes: A Systematic Review. Current Oncology 2023; 30(7): 6734 doi: 10.3390/curroncol30070494
|
8 |
Ruby Dwivedi, Ayushi Jain, Shalini Gupta, Shaleen Chandra. Immunotherapy: The Fourth Domain in Oral Cancer Therapeutics. Indian Journal of Otolaryngology and Head & Neck Surgery 2024; doi: 10.1007/s12070-024-04565-3
|
9 |
Katarzyna Starska-Kowarska. The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy. Cancers 2023; 15(6): 1642 doi: 10.3390/cancers15061642
|
10 |
Yizhou Yang, Zeman Cai, Kaichun Huang, Mei Li, Xiao Wang, Yinbing Lin, Sijie Chen, Zhining Yang, Zhixiong Lin. A composite score based on immune-related gene prognostic index and m6A risk score of head and neck squamous cell carcinoma. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1061569
|
11 |
Sonja Steen, Karl Semmelmayer, Christa Flechtenmacher, Jürgen Hoffmann, Kolja Freier, Dominik Horn, Jochen Hess, Christian Freudlsperger, Julius Moratin. Dynamic Up-Regulation of PD-L1 in the Progression of Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences 2023; 24(22): 16386 doi: 10.3390/ijms242216386
|